CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B CellsLei Tao, Wenzheng Jiang, Congyi Niu et al.|Cancers|2020Cited by 36
TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-κb signaling pathwayMuhammad Asad Farooq, Wenzheng Jiang|Journal of Translational Medicine|2026Cited by 2